120 related articles for article (PubMed ID: 7656487)
21. A review of the use of chemoprotectants in cancer chemotherapy.
Lewis C
Drug Saf; 1994 Sep; 11(3):153-62. PubMed ID: 7811398
[TBL] [Abstract][Full Text] [Related]
22. The ACTH(4-9) analog ORG 2766 and recovery after brain damage in animal models--a review.
van Rijzingen IM; Gispen WH; Spruijt BM
Behav Brain Res; 1996 Jan; 74(1-2):1-15. PubMed ID: 8851911
[TBL] [Abstract][Full Text] [Related]
23. Cisplatin ototoxicity involves organ of Corti, stria vascularis and spiral ganglion: modulation by alphaMSH and ORG 2766.
Hamers FP; Wijbenga J; Wolters FL; Klis SF; Sluyter S; Smoorenburg GF
Audiol Neurootol; 2003; 8(6):305-15. PubMed ID: 14566101
[TBL] [Abstract][Full Text] [Related]
24. Retreatment with dose-dense weekly cisplatin after previous cisplatin chemotherapy is not complicated by significant neuro-toxicity.
van den Bent MJ; van Putten WL; Hilkens PH; de Wit R; van der Burg ME
Eur J Cancer; 2002 Feb; 38(3):387-91. PubMed ID: 11818204
[TBL] [Abstract][Full Text] [Related]
25. Treatment of diabetic polyneuropathy with the neurotrophic peptide ORG 2766.
Valk GD; Kappelle AC; Tjon-A-Tsien AM; Bravenboer B; Bakker K; Michels RP; Groenhout CM; Bertelsmann FW
J Neurol; 1996 Mar; 243(3):257-63. PubMed ID: 8936356
[TBL] [Abstract][Full Text] [Related]
26. Early visual information processing in depressive patients treated with ORG 2766 (an ACTH 4-9 analogue).
d'Elia G; Frederiksen SO; Bengtsson BO
Neuropsychobiology; 1985; 13(1-2):63-8. PubMed ID: 2993946
[TBL] [Abstract][Full Text] [Related]
27. The effect of the adrenocorticotropin-(4-9) analogue, ORG 2766, and of dizolcipine (MK-801) on infarct volume in rat brain.
Herz RC; Kasbergen CM; Versteeg DH; De Wildt DJ
Eur J Pharmacol; 1998 Apr; 346(2-3):159-65. PubMed ID: 9652355
[TBL] [Abstract][Full Text] [Related]
28. The MSH/ACTH analog ORG 2766 in anxiety disorders.
Den Boer JA; Westenberg HG; De Vries H
Peptides; 1992; 13(1):109-12. PubMed ID: 1320259
[TBL] [Abstract][Full Text] [Related]
29. Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin.
Hilkens PH; Pronk LC; Verweij J; Vecht CJ; van Putten WL; van den Bent MJ
Br J Cancer; 1997; 75(3):417-22. PubMed ID: 9020489
[TBL] [Abstract][Full Text] [Related]
30. Histological effects of co-administration of an ACTH((4-9)) analogue, ORG 2766, on cisplatin ototoxicity in the albino guinea pig.
Cardinaal RM; de Groot JC; Huizing EH; Veldman JE; Smoorenburg GF
Hear Res; 2000 Jun; 144(1-2):157-67. PubMed ID: 10831874
[TBL] [Abstract][Full Text] [Related]
31. Org.2766 protects from cisplatin-induced neurotoxicity in rats.
de Koning P; Neijt JP; Jennekens FG; Gispen WH
Exp Neurol; 1987 Sep; 97(3):746-50. PubMed ID: 3040462
[TBL] [Abstract][Full Text] [Related]
32. Beneficial effect of Org 2766 in treatment of peripheral neuropathy in streptozocin-induced diabetic rats.
Van der Zee CE; Van der Hoop RG; Gispen WH
Diabetes; 1989 Feb; 38(2):225-30. PubMed ID: 2536628
[TBL] [Abstract][Full Text] [Related]
33. Double-blind, multicenter, randomized trial to compare the effect of two doses of adrenocorticotropic hormone versus placebo in controlling delayed emesis after high-dose cisplatin in adult patients with cancer.
Passalacqua R; Cocconi G; Caminiti C; Silingardi V; Bella MA; Bichisao E; Michiara M; Malavasi V; Donati D; Di Costanzo F; Rocca A; Di Sarra S; Scaglione F; Fraschini F
J Clin Oncol; 1997 Jun; 15(6):2467-73. PubMed ID: 9196163
[TBL] [Abstract][Full Text] [Related]
34. Reduction of amygdaloid kindled seizures by an analog of ACTH/MSH.
Goldman H; Berman RF
Peptides; 1984; 5(6):1061-5. PubMed ID: 6099557
[TBL] [Abstract][Full Text] [Related]
35. Adrenocorticotropic hormone in the prevention of cisplatin-induced nausea and vomiting.
Colbert N; Izrael V; Lotz JP; Stoppa-Lyonnet D; Vannetzel JM; Pene F; Schlienger M; Laugier A
J Clin Oncol; 1983 Oct; 1(10):635-9. PubMed ID: 6321674
[TBL] [Abstract][Full Text] [Related]
36. The ACTH-(4-9) analog, ORG 2766, prevents taxol-induced neuropathy in rats.
Hamers FP; Pette C; Neijt JP; Gispen WH
Eur J Pharmacol; 1993 Mar; 233(1):177-8. PubMed ID: 8097161
[TBL] [Abstract][Full Text] [Related]
37. Protection against cisplatin induced neurotoxicity by ORG 2766: histological and electrophysiological evidence.
Gerritsen van der Hoop R; Hamers FP; Neijt JP; Veldman H; Gispen WH; Jennekens FG
J Neurol Sci; 1994 Nov; 126(2):109-15. PubMed ID: 7853014
[TBL] [Abstract][Full Text] [Related]
38. Morphological and electrophysiological study of the effects of cisplatin and ORG.2766 on rat spinal ganglion neurons.
Müller LJ; Gerritsen van der Hoop R; Moorer-van Delft CM; Gispen WH; Roubos EW
Cancer Res; 1990 Apr; 50(8):2437-42. PubMed ID: 2156619
[TBL] [Abstract][Full Text] [Related]
39. The ACTH (4-9) analog ORG 2766 in panic disorder: a preliminary study.
den Boer JA; Westenberg HG; Mastenbroek B; van Ree JM
Psychopharmacol Bull; 1989; 25(2):204-8. PubMed ID: 2557650
[No Abstract] [Full Text] [Related]
40. Treatment of Alzheimer's disease with a synthetic ACTH 4-9 analog.
Soininen H; Koskinen T; Helkala EL; Pigache R; Riekkinen PJ
Neurology; 1985 Sep; 35(9):1348-51. PubMed ID: 2991817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
